217 related articles for article (PubMed ID: 18692928)
21. Dose escalation with proton or photon radiation treatment for pancreatic cancer.
Bouchard M; Amos RA; Briere TM; Beddar S; Crane CH
Radiother Oncol; 2009 Aug; 92(2):238-43. PubMed ID: 19454367
[TBL] [Abstract][Full Text] [Related]
22. Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment option.
Mock U; Georg D; Sölkner L; Suppan C; Vatnitsky SM; Flechl B; Mayer R; Dieckmann K; Knäusl B
Radiother Oncol; 2014 Jun; 111(3):451-6. PubMed ID: 25012644
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric comparison of four different external beam partial breast irradiation techniques: three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy.
Moon SH; Shin KH; Kim TH; Yoon M; Park S; Lee DH; Kim JW; Kim DW; Park SY; Cho KH
Radiother Oncol; 2009 Jan; 90(1):66-73. PubMed ID: 18992950
[TBL] [Abstract][Full Text] [Related]
24. Comparison of conventional to intensity modulated radiation therapy for abdominal neuroblastoma.
Paulino AC; Ferenci MS; Chiang KY; Nowlan AW; Marcus RB
Pediatr Blood Cancer; 2006 Jun; 46(7):739-44. PubMed ID: 16302219
[TBL] [Abstract][Full Text] [Related]
25. Comparison of surface doses from spot scanning and passively scattered proton therapy beams.
Arjomandy B; Sahoo N; Cox J; Lee A; Gillin M
Phys Med Biol; 2009 Jul; 54(14):N295-302. PubMed ID: 19550003
[TBL] [Abstract][Full Text] [Related]
26. Second cancers in children treated with modern radiotherapy techniques.
Schneider U; Lomax A; Timmermann B
Radiother Oncol; 2008 Nov; 89(2):135-40. PubMed ID: 18707783
[TBL] [Abstract][Full Text] [Related]
27. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
Jones B
J Radiol Prot; 2009 Jun; 29(2A):A143-57. PubMed ID: 19454805
[TBL] [Abstract][Full Text] [Related]
28. Dose escalation in the radiotherapy of non-small-cell lung cancer with aperture-based intensity modulation and photon beam energy optimization for non-preselected patients.
St-Hilaire J; Sévigny C; Beaulieu F; Germain F; Lavoie C; Dagnault A; Gingras L; Tremblay D; Beaulieu L
Radiother Oncol; 2009 Jun; 91(3):342-8. PubMed ID: 19135749
[TBL] [Abstract][Full Text] [Related]
29. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
30. Optimization of physical dose distributions with hadron beams: comparing photon IMRT with IMPT.
Oelfke U; Bortfeld T
Technol Cancer Res Treat; 2003 Oct; 2(5):401-12. PubMed ID: 14529305
[TBL] [Abstract][Full Text] [Related]
31. Dosimetric comparison between proton and photon beams in the moving gap region in cranio-spinal irradiation (CSI).
Cheng CW; Das IJ; Srivastava SP; Zhao L; Wolanski M; Simmons J; Johnstone PA; Buchsbaum JC
Acta Oncol; 2013 Apr; 52(3):553-60. PubMed ID: 22554342
[TBL] [Abstract][Full Text] [Related]
32. Assessment of improved organ at risk sparing for advanced cervix carcinoma utilizing precision radiotherapy techniques.
Georg D; Georg P; Hillbrand M; Pötter R; Mock U
Strahlenther Onkol; 2008 Nov; 184(11):586-91. PubMed ID: 19016017
[TBL] [Abstract][Full Text] [Related]
33. DVHs evaluation in brain metastases stereotactic radiotherapy treatment plans.
Pasciuti K; Iaccarino G; Soriani A; Bruzzaniti V; Marzi S; Gomellini S; Arcangeli S; Benassi M; Landoni V
Radiother Oncol; 2008 Apr; 87(1):110-5. PubMed ID: 18207593
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of movement-induced dose reduction in target volume: a comparison between photon and proton beam treatment.
Yoon M; Shin D; Kwak J; Park S; Lim YK; Kim D; Park SY; Lee SB; Shin KH; Kim TH; Cho KH
Med Dosim; 2009; 34(3):191-201. PubMed ID: 19647628
[TBL] [Abstract][Full Text] [Related]
35. Can particle beam therapy be improved using helium ions? - a planning study focusing on pediatric patients.
Knäusl B; Fuchs H; Dieckmann K; Georg D
Acta Oncol; 2016 Jun; 55(6):751-9. PubMed ID: 26750803
[TBL] [Abstract][Full Text] [Related]
36. Reassessing dose constraints of organs at risk in children with abdominal neuroblastoma treated with definitive radiation therapy: a correlation with late toxicity.
Kandula S; Sutter A; Prabhu RS; Jegadeesh N; Esiashvili N
Pediatr Blood Cancer; 2015 Jun; 62(6):970-5. PubMed ID: 25545501
[TBL] [Abstract][Full Text] [Related]
37. Proton radiation therapy for head and neck cancer.
Chan AW; Liebsch NJ
J Surg Oncol; 2008 Jun; 97(8):697-700. PubMed ID: 18493920
[TBL] [Abstract][Full Text] [Related]
38. Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours?
Sharma SD; Jalali R; Phurailatpam RD; Gupta T
Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):408-16. PubMed ID: 19268555
[TBL] [Abstract][Full Text] [Related]
39. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques.
Johansen S; Cozzi L; Olsen DR
Acta Oncol; 2009; 48(4):495-503. PubMed ID: 19169915
[TBL] [Abstract][Full Text] [Related]
40. [Clinical problems of radiotherapy in pediatric oncology].
Goldobenko GV; Durnov LA; Kanaev SV
Vopr Onkol; 1997; 43(4):439-42. PubMed ID: 9381700
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
